Catalyst Wire Dossier Catalyst Wire Dossier

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Buprenorphine hydrochloride and naloxone hydrochloride · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, covering 2026-08-14 to 2026-08-14. Get the full timeline:

Most recent: FDA Approved: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE — Supplemental Application (TEVA PHARMS USA)

See pricing